相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of Novel, Potent, Brain-Permeable, and Orally Efficacious Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptor [4-(5-(4-Chlorophenyl)-4-methyl-2-propionylthiophen-3-yl)benzenesulfonamide]: Structure-Activity Relationship and Preclinical Characterization
Neelima Sinha et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Efficacy and cognitive effect of sarcosine (N-methylglycine) in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials
Chun-Hung Chang et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management
Kevin C. F. Fone et al.
MOLECULAR NEUROBIOLOGY (2020)
The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents
Holger Rosenbrock et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
The increase in medial prefrontal glutamate/glutamine concentration during memory encoding is associated with better memory performance and stronger functional connectivity in the human medial prefrontal-thalamus-hippocampus network
Jan-Willem Thielen et al.
HUMAN BRAIN MAPPING (2018)
Validation and optimisation of a touchscreen progressive ratio test of motivation in male rats
Jonathan M. Hailwood et al.
PSYCHOPHARMACOLOGY (2018)
The GlyT1 Inhibitor Bitopertin Ameliorates Allodynia and Hyperalgesia in Animal Models of Neuropathic and Inflammatory Pain
Anja Armbruster et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Evaluation of Pharmacokinetics and Pharmacodynamics of BI 425809, a Novel GlyT1 Inhibitor: Translational Studies
Holger Rosenbrock et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
Neurophysiological Effects of Bitopertin in Schizophrenia
Joshua T. Kantrowitz et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
Functional Connectivity of Multiple Brain Regions Required for the Consolidation of Social Recognition Memory
Toshiyuki Tanimizu et al.
JOURNAL OF NEUROSCIENCE (2017)
Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions
Samantha E. Yohn et al.
PSYCHOPHARMACOLOGY (2017)
Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte Studies
Dragana Bugarski-Kirola et al.
BIOLOGICAL PSYCHIATRY (2017)
Effects of the glycine reuptake inhibitors bitopertin and RG7118 on glycine in cerebrospinal fluid: results of two proofs of mechanism studies in healthy volunteers
Carsten Hofmann et al.
PSYCHOPHARMACOLOGY (2016)
Efficacy of a glycine transporter 1 inhibitor TASP0315003 in animal models of cognitive dysfunction and negative symptoms of schizophrenia
Shigeyuki Chaki et al.
PSYCHOPHARMACOLOGY (2015)
A phase II/III trial of bitopertin monotherapy compared with placebo in patients with an acute exacerbation of schizophrenia - Results from the CandleLyte study
D. Bugarski-Kirola et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats
S. Sommer et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Relationship Between Glycine Transporter I Inhibition as Measured with Positron Emission Tomography and Changes in Cognitive Performances in Nonhuman Primates
S. A. Castner et al.
NEUROPSYCHOPHARMACOLOGY (2014)
The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey
Donnie Eddins et al.
PSYCHOPHARMACOLOGY (2014)
Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia A Randomized, Double-Blind, Proof-of-Concept Study
Daniel Umbricht et al.
JAMA PSYCHIATRY (2014)
A novel liquid chromatography/tandem mass spectrometry method for the quantification of glycine as biomarker in brain microdialysis and cerebrospinal fluid samples within 5 min
Patrizia Voehringer et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
The global cognitive impairment in schizophrenia: Consistent over decades and around the world
Jonathan Schaefer et al.
SCHIZOPHRENIA RESEARCH (2013)
NMDA Receptor Activity in Neuropsychiatric Disorders
Shaheen E. Lakhan et al.
Frontiers in Psychiatry (2013)
Glutamate Receptor Abnormalities in Schizophrenia: Implications for Innovative Treatments
Maria D. Rubio et al.
BIOMOLECULES & THERAPEUTICS (2012)
Motivational states influence effort-based decision making in rats: The role of dopamine in the nucleus accumbens
Bettina Mai et al.
COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE (2012)
A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease
Katsuya Harada et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia
Daniela Alberati et al.
NEUROPHARMACOLOGY (2012)
A less stressful alternative to oral gavage for pharmacological and toxicological studies in mice
Mary K. Walker et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia
Kenji Hashimoto
CURRENT PHARMACEUTICAL DESIGN (2011)
A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia
Hsien-Yuan Lane et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents
N. M. W. J. de Bruin et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2010)
Glycine transporter inhibition reverses ketamine-induced working memory deficits
Brooke M. Roberts et al.
NEUROREPORT (2010)
Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
Joanna C. Neill et al.
PHARMACOLOGY & THERAPEUTICS (2010)
d-Serine and a glycine transporter-1 inhibitor enhance social memory in rats
Toshiharu Shimazaki et al.
PSYCHOPHARMACOLOGY (2010)
The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents
F. Josef van der Staay et al.
NEUROPHARMACOLOGY (2008)
Expression of D-serine and glycine transporters in the prefrontal cortex and cerebellum in schizophrenia
P. W. J. Burnet et al.
SCHIZOPHRENIA RESEARCH (2008)
Effects of novel antipsychotics with mixed D2 antagonist/5-HT1A agonist properties on PCP-induced social interaction deficits in the rat
LAB Slot et al.
NEUROPHARMACOLOGY (2005)
Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia - A randomized, double-blind, placebo-controlled study
HY Lane et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-I SSR504734, a potential new type of antipsychotic
R Depoortère et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to antipsychotics for the treatment of schizophrenia
GC Tsai et al.
BIOLOGICAL PSYCHIATRY (2004)
Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels
M Martina et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
The T-maze continuous alternation task for assessing the effects of putative cognition enhancers in the mouse
L Spowart-Manning et al.
BEHAVIOURAL BRAIN RESEARCH (2004)
Glycine binding primes NMDA receptor internalization
Y Nong et al.
NATURE (2003)
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia
DC Goff et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Discovery and SAR of Org 24598 - A selective glycine uptake inhibitor
A Brown et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
分享论文
